You are here » Home » Companies » Company Overview » KMC Speciality Hospitals (India) Ltd

KMC Speciality Hospitals (India) Ltd.

BSE: 524520	Sector: Health care
NSE: N.A.	ISIN Code: INE879K01018

BSE 00:00 | 29 Sep

21.65

-0.15
(-0.69%)

OPEN

22.25

HIGH

22.25

LOW

21.60

NSE 05:30 | 01 Jan

KMC Speciality Hospitals (India) Ltd

Add to Watchlist | Add to Portfolio

OPEN	22.25
PREVIOUS CLOSE	21.80
VOLUME	17054
52-Week high	26.50
52-Week low	9.51
P/E	36.69
Mkt Cap.(Rs cr)	353
Buy Price	21.65
Buy Qty	250.00
Sell Price	21.85
Sell Qty	200.00

OPEN	22.25
CLOSE	21.80
VOLUME	17054
52-Week high	26.50
52-Week low	9.51
P/E	36.69
Mkt Cap.(Rs cr)	353
Buy Price	21.65
Buy Qty	250.00
Sell Price	21.85
Sell Qty	200.00

Click here for interactive graph

KMC Speciality Hospitals (India) Ltd. (KMCSPECIALITY) - News Sector

Strides Pharma hits a fresh 52-week high; stock gains 14% in one week

1.22 pm | 29 Sep 2020 | Business Standard

The company had reported a strong improvement in profitability in Q1 despite Ranitidine suspension in Q4.
Stock tips by Nilesh Jain of Anand Rathi: Buy Radico Khaitan, Shoppers Stop

8.00 am | 29 Sep 2020 | Business Standard

The stock of Radico Khaitan has found the support of its rising trend line and has also formed a reversal candle on the daily chart
Apollo will be stronger, more consumer-centric post Covid: Suneeta Reddy

4.24 pm | 28 Sep 2020 | Business Standard

In a Q&A, the MD of Apollo Hospitals on how her company is strengthening its chains in order to come closer to the consumer
Sun Pharma closes share buyback offer period; stock jumps 5%

3.00 pm | 28 Sep 2020 | Business Standard

The drug major is looking to expand its specialty business across different regions like Greater China and Japan after having established presence in ...
Laurus Labs surges 6% as stock to turn ex-date for 1:5 split on Tuesday

10.42 am | 28 Sep 2020 | Business Standard

The board has fixed September 30, 2020 as the 'record date' for sub-division of equity shares of the company from existing face value of Rs 10 each to...
Indoco Remedies rallies 9% after launching Covid treatment drug

9.41 am | 28 Sep 2020 | Business Standard

Fevindo-400 will be made available at all government approved COVID care centres and selected medical practitioners across the country
Strong support exists for Nifty at 10,900: CapitalVia Global Research

9.04 am | 28 Sep 2020 | Business Standard

A short-covering move, along with addition of fresh position, is seen only if somehow Nifty sustains level of 11,200
Dr Reddy's enters Rs 28,000 cr market with multiple sclerosis drug in US

6.22 pm | 26 Sep 2020 | Press Trust of India

The company's product is a therapeutic equivalent generic version of Biogen's Tecfidera delayed-release capsules, the Hyderabad-based drug firm said i...
Cipla surges 5% on USFDA approval for dimethyl fumarate DR capsules

1.15 pm | 25 Sep 2020 | Business Standard

The drug, indicated for treatment of relapsing forms of multiple sclerosis, had annual US sales of US$3.8 billion as per IQVIA MAT July 2020.
Granules India up 5% on USFDA approval for generic Aleve PM tablets

12.40 pm | 25 Sep 2020 | Business Standard

According to media reports, global private equity firms have expressed interest in acquiring a controlling stake in the company
Stocks to watch: IT stks, Cipla, RIL, TCS, Tata Coffee, Mahindra & Mahindra

8.52 am | 25 Sep 2020 | Business Standard

Here's a list of stocks that may trade actively in today's session
Stock recommendations by Anand Rathi: Sell Piramal Enterprises, L&T Finance

8.08 am | 25 Sep 2020 | Business Standard

The momentum oscillator MACD has provided fresh sell crossover on the weekly scale for Piramal's stock
Syngene: Investors with long term view should look at the stock on dips

1.17 am | 25 Sep 2020 | Business Standard

While Covid-19 could is a near term opportunity, contract manufacturing is the key medium-term trigger
Nearly half of BSE 500 stocks underperform market since March low

1.05 am | 25 Sep 2020 | Business Standard

The S&P BSE 500 index, which accounts for 94 per cent market capitalisation of BSE listed companies, has gained 45 per cent from its March 24 low.
Emami, IPCA Labs: 5 defensive stocks you can buy in the current market

12.08 pm | 24 Sep 2020 | Business Standard

Despite the market correction, there are some stocks from the FMCG and pharma sectors - considered classic defensive plays - that can be bought from a...
Emami, IPCA Labs: 5 defensive stocks you can buy in the current market

12.08 pm | 24 Sep 2020 | Business Standard

Despite the market correction, there are some stocks from the FMCG and pharma sectors - considered classic defensive plays - that can be bought from a...
Emami, IPCA Labs: 5 defensive stocks you can buy in the current market

12.08 pm | 24 Sep 2020 | Business Standard

Despite the market correction, there are some stocks from the FMCG and pharma sectors - considered classic defensive plays - that can be bought from a...
Apollo Hospitals surges 21% in 2 weeks post Q1 results; stock hits new high

12.05 pm | 24 Sep 2020 | Business Standard

Analysts see Apollo going back to its hospital margin expansion trajectory in FY22 to help drive cash generation and debt reduction
Syngene Int'l hits record high in a weak market, rallies 26% in two weeks

10.46 am | 24 Sep 2020 | Business Standard

The stock rallied 6.5 per cent to Rs 596.85, surpassing its previous high Rs 594.75, touched on September 15, 2020, on the BSE.
India's Covid diplomacy: US to Russia, Delhi part of every vaccine alliance

1.47 am | 24 Sep 2020 | Business Standard

India is party to Sputnik-V, the vaccine under development jointly by Russia's Gamaleya National Research Institute of Epidemiology and Microbiology a...